AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 161 filers reported holding AIMMUNE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $2,000 | -98.6% | 136 | -98.6% | 0.00% | -100.0% |
| Q1 2020 | $144,000 | +2780.0% | 9,936 | +7205.9% | 0.00% | – |
| Q4 2019 | $5,000 | +66.7% | 136 | 0.0% | 0.00% | – |
| Q3 2019 | $3,000 | 0.0% | 136 | 0.0% | 0.00% | – |
| Q2 2019 | $3,000 | 0.0% | 136 | 0.0% | 0.00% | – |
| Q1 2019 | $3,000 | 0.0% | 136 | 0.0% | 0.00% | – |
| Q4 2018 | $3,000 | -25.0% | 136 | 0.0% | 0.00% | – |
| Q3 2018 | $4,000 | – | 136 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|